Better Drugs, Hep C Testing and Baby Boomers
New drugs take aim at hepatitis C, spur debate on whether to test baby boomers
By Lauran Neergaard (CP) – Jan 17, 2011
WASHINGTON — There’s new hope for an overlooked epidemic: Two powerful drugs are nearing the market that promise to help cure many more people of liver-attacking hepatitis C — even though most who have the simmering infection don’t know it yet.
Surprisingly, two-thirds of hepatitis C sufferers are thought to be baby boomers who’ve harboured since their younger, perhaps wilder, years a virus that can take two or three decades to do its damage.
What could be a treatment revolution is spurring the government to consider if it’s time to start screening aging baby boomers for hepatitis C, just like they get various cancer checks.
Continue reading this entire article:
Bavituximab to Star in Phase II Hepatitis C Trial
Telaprevir Receives Quick FDA Review